Skip to content

Mar Fatjó‐Vilas

7 papers in the library · 2 citations · publishing 2011-2024

Papers

Sort Most recent Most cited

Clinical and cognitive outcomes in first-episode psychosis: focus on the interplay between cannabis use and genetic variability in endocannabinoid receptors

Frontiers in Psychology August 12, 2024 Maitane Oscoz-Irurozqui, Maria Guardiola-Ripoll, Carmen Almodóvar-Payá et al.

Introduction Research data show the impact of the endocannabinoid system on psychosis through its neurotransmission homeostatic functions. However, the effect of the endocannabinoid system genetic variability on the relationship between cannabis use and psychosis has been unexplored, even less in first-episode patients. Here, through a case-only design, we investigated the effect of cannabis...

Cannabis Use and Endocannabinoid Receptor Genes: A Pilot Study on Their Interaction on Brain Activity in First-Episode Psychosis

International Journal of Molecular Sciences April 19, 2023 Maitane Oscoz-Irurozqui, Carmen Almodóvar-Payá, Maria Guardiola-Ripoll et al. 2 citations

The role of both cannabis use and genetic background has been shown in the risk for psychosis. However, the effect of the interplay between cannabis and variability at the endocannabinoid receptor genes on the neurobiological underpinnings of psychosis remains inconclusive. Through a case-only design, including patients with a first-episode of psychosis (n = 40) classified as cannabis users...

DOI: 10.3390/ijms24087501 (opens in new tab) Cannabis Psychosis Endocannabinoid system Cannabinoid receptor +9

Cannabis use and genes of endocannabinoid system: their role in psychotic symptoms and cognition in first-episode psychosis.

2020 Maitane Oscoz-Irurozqui, Maria Guardiola-Ripoll, Carmen Almodóvar-Payá et al.

Objectives. To evaluate the association of cannabis use, genes of the endocannabinoid system and their interaction on clinical symptoms and cognitive performance in patients with a first-episode of pyschosis. Background. The role of both cannabis use and individual genetic background has been shown in the risk for psychosis. However, the influence of cannabis and variability at endocannabinoid...

The interaction between the ZNF804A gene and cannabis use on the risk of psychosis in a non‐clinical sample

Progress in Neuro-Psychopharmacology and Biological Psychiatry March 1, 2019 Joaquim Soler, Bárbara Arias, Jorge Moya et al.

ABSTRACT The ZNF804A gene and cannabis use are risk factors for psychosis and both have also been associated with schizotypal traits. This study aimed to investigate: i) the association of lifetime cannabis use (and its dose effect) with schizotypal personality traits, and ii) whether the genetic variability at ZNF804A gene modulates that association. Our sample consisted of 385 Spanish...

S17. ZNF804A GENE AND CANNABIS USE: INTERACTION ON THE RISK FOR PSYCHOSIS IN A NON-CLINICAL SAMPLE

Schizophrenia Bulletin April 1, 2018 Jordi Soler García, Bárbara Arias, Jorge Moya et al.

Abstract Background The ZNF804A gene and cannabis use are risk factors for psychosis, both of which have also been associated with schizotypic traits. This study aimed to test whether ZNF804A (rs1344706) modulates the relation between cannabis use and schizotypy levels in a general population sample. Methods The sample consisted of 389 Spanish non-clinical subjects (43% males, mean...

[Basic symptoms in schizophrenia, their clinical study and relevance in research].

Revista de psiquiatria y salud mental 2016 Salvador Miret, Mar Fatjó‐Vilas, Víctor Peralta et al.

Basic symptoms consist of subtle sub-clinical disturbances subjectively experienced by schizophrenia patients. These are mainly related to drive, affect, thinking and language, perception, memory, motor action, central vegetative functions, control of cognitive processes, and stress tolerance. Initially described by Huber, from a phenomenological approach, basic symptoms are part of the...